These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 4390126)

  • 1. Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.
    Bartholini G; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):323-4. PubMed ID: 4390126
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine.
    Berry MD; Scarr E; Zhu MY; Paterson IA; Juorio AV
    Br J Pharmacol; 1994 Dec; 113(4):1159-66. PubMed ID: 7889269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of intracerebroventricular GABA, glycine and muscimol in the rat.
    Persson B
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):225-36. PubMed ID: 7432555
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of Parkinson's disease: basic aspects and recent advances.
    Da Prada M; Keller HH; Pieri L; Kettler R; Haefely WE
    Experientia; 1984 Nov; 40(11):1165-72. PubMed ID: 6437857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of l-DOPA and benserazide on the amount of dopamine in the corpus striatum of X-irradiated rats.
    Stepanović SR; Nikolić J
    Experientia; 1983 Sep; 39(9):1050-1. PubMed ID: 6411487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U
    Psychopharmacologia; 1970 Aug; 18(1):58-67. PubMed ID: 5535577
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.
    Tate SS; Sweet R; McDowell FH; Meister A
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2121-3. PubMed ID: 5289372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs.
    Minsker DH; Scriabine A; Stokes AL; Stone CA; Torchiana ML
    Experientia; 1971 May; 27(5):529-31. PubMed ID: 5132586
    [No Abstract]   [Full Text] [Related]  

  • 10. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 11. Aphrodisiac effect of L-DOPA and apomorphine in male sexually sluggish rats.
    Tagliamonte A; Fratta W; Gessa GL
    Experientia; 1974 Apr; 30(4):381-2. PubMed ID: 4837624
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-tryptophan on motor activity in mice.
    Modigh K
    Psychopharmacologia; 1973 May; 30(2):123-34. PubMed ID: 4711370
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacologia; 1973; 29(4):289-98. PubMed ID: 4707021
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
    Schneider E; Fischer PA; Jacobi P; Maxion H
    Arch Psychiatr Nervenkr (1970); 1973 Mar; 217(1):95-112. PubMed ID: 4695662
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of bulbospinal monoaminergic pathways on sympathetic nerve activity.
    Coote JH; Macleod VH
    J Physiol; 1974 Sep; 241(2):453-75. PubMed ID: 4548438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chlorimipramine and protriptyline on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice.
    Modigh K
    J Neural Transm; 1973; 34(2):101-9. PubMed ID: 4541821
    [No Abstract]   [Full Text] [Related]  

  • 17. Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice.
    Modigh K
    Psychopharmacologia; 1972; 23(1):48-54. PubMed ID: 4537019
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of L0dopa, clonidine, and apomorphine on the acoustic startle reaction in rats.
    Fechter LD
    Psychopharmacologia; 1974; 39(4):331-44. PubMed ID: 4449930
    [No Abstract]   [Full Text] [Related]  

  • 19. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1971; 2(4):262-400. PubMed ID: 4340597
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of seizures induced by a catechol-derivative.
    Kellogg C; LaMantia J; Jacobson J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(3):257-72. PubMed ID: 4282117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.